Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH Funding Component of 21st Century Cures May Get White House Boost

Executive Summary

Vice President’s Cancer Moonshot project could provide final thrust for '21st Century Cures' bill in the lame duck Congressional session after election.

Advertisement

Related Content

The Unlikely Savior Of 21st Century Cures: Donald Trump
The Unlikely Savior Of ‘21st Century Cures’ Is Donald Trump
Regenerative Medicine In Cures: Conditional Approval Dropped In Lieu Of ‘Breakthrough’-Style Approach
Clinical Trial Disclosure Rule Warns Of Legal Penalties For Failure To Submit
Quest For Political Capital, Legacy Could Push 'Cures' Over The Finish Line
FDA's Pazdur Won't Become Oncology Bureaucrat: 'My Presence Will Be Felt'
Regulating Cell Therapies: Conditional Approval Under Consideration In Congress; FDA Plans Public Hearing
New US Compassionate Use Tool Would Need Support Of Drug Makers

Topics

Advertisement
UsernamePublicRestriction

Register

PS119388

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel